http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Sumin Ha(하수민),Tae Hyun Kim(김태현),Anbok Lee(이안복),Kyung-Do Byun(변경도),Jae Woong Han(한재웅),Min Sung Ahn(안민성),Kwang Hee Kim(김광희),Ki Beom Bae(배기범),Ha Kyoung Park(박하경),Jae Ho Shin(신재호),Sang Hyuk Seo(서상혁) 대한종양외과학회 2015 Korean Journal of Clinical Oncology Vol.11 No.2
Purpose: Oncoplastic surgery (OPS) has emerged as the latest ideal surgery in treatment of breast cancer. The purpose of this study is to evaluate the cosmetic outcome of volume displacement surgery and patients’ satisfaction in Korean women with relatively small breast size. Methods: This is a retrospective study of 173 patients who had volume displacement of OPS between January 2008 and December 2013. Cosmetic outcome was evaluated by patients’ questionnaire and a doctor. The patients’ satisfaction was assessed by a questionnaire divided into four categories; cosmetic satisfaction, satisfaction on operative method, femininity, and side effects. Relationship between removed specimen volume and patients’ satisfaction was also analyzed. Results: About 90% of patients answered above the fair in cosmetic items and operative methods, only less than 5% of all patients reported of severe complications such as cramps or limitations of exercise. The patients’ cosmetic satisfaction score were significantly inversely related with removed specimen volume and doctor’s cosmetic assessment was also accordance with this result (P<0.05). Most patients preferred good contour over short scar regardless of age and marital status (good contour 54% vs. short scar 21%). Conclusion: Volume displacement of OPS brings both the best possible cosmetic outcome and high patient satisfaction for Korean women with a small size of breast in breast cancer surgery. It is highly suggestive that Korean women considers good contour more than the size of scar; therefore, volume displacement of OPS is a recommendable means of breast cancer surgery for Korean women.
하시모토 갑상선염을 동반한 유두상 갑상선암의 임상병리학적 특징
강상현,하태권,박하경,이홍태,신재호,안민성,김광희,배기범,김태현,최창수,김진수<SUP>1<.SUP>,김기훈<SUP>1<.SUP>,김운원<SUP>1<.SUP>,김상효,Sang Hyun Kang,Tae Kwun Ha,Ha Kyoung Park,Hong Tae Lee,Jae Ho Shin,Min Sung Ahn,Kwang Hee Kim,Ki Beom Bae,Ta 대한갑상선-내분비외과학회 2013 The Koreran journal of Endocrine Surgery Vol.13 No.1
Purpose: Hashimoto's thyroiditis (HT) is an important cause of hypothyroidism caused by autoimmune chronic lymphocytic thyroiditis. In order to attain a better understanding for use in treatment of papillary thyroid carcinoma (PTC) coexisting with HT, we conducted an analysis of the clinicopathologic features, as well as the importance of HT as a prognostic factor. Methods: In this retrospective study, we analyzed 341 patients who were histopathologically diagnosed with PTC following surgery. Results: PTC coexisting with HT was observed in 19.6% (67 patients) of all PTC patients. A statistically significant gender difference was observed in the group with HT (two male vs. 65 female), with a higher positive rate of anti-thyroglobulin antibody and smaller tumor size, compared to the PTC group without HT. When tumor size increased, a lower coexistence rate of HT was observed. No significant differences were observed in multifocality, cervical lymph node (LN) metastasis, coexistence of benign nodule, and extent of LN dissection. However, frequency of extrathyroidal extension was significantly lower and total thyroidectomy rate was higher in the group with HT. TNM stage and AMES stage were similar in both groups; frequency of high MACIS score showed a significant decrease in the group with HT. The recurrence rate and disease-free survival in patients with PTC were not significantly affected by coexistence of HT. Conclusion: We found a significant relationship with gender, extrathyroidal extension, and tumor size in PTC coexisting with HT. However, no significant differences in recurrence rate and disease-free survival were observed between groups. Therefore, coexistence in PTC could not be applicable as a prognostic factor of PTC.
직장암에서 복강경 수술과 개복 수술 후 단기간의 종양학적 결과에 대한 비교
최낙준(Nak Jun Choi),유종한(Jong Han Yoo),이홍태(Hong Tae Lee),신재호(Jae Ho Shin),박하경(Ha Kyoung Park),안민성(Min Sung An),하태권(Tae Kwun Ha),김광희(Kwang Hee Kim),배기범(Ki Beom Bae),김태현(Tae Hyun Kim),최창수(Chang Soo Choi),오 대한종양외과학회 2013 Korean Journal of Clinical Oncology Vol.9 No.1
Purpose: The aim of this study was to assess the impact of laparoscopic vs. conventional open surgery for rectal cancer on clinical and oncologic outcome in a multi-modal setting. Methods: In total, 940 patients who underwent conventional open surgery between February 1995 and October 2007, and 311 patients who underwent laparoscopic surgery between December 2006 and May 2011 were enrolled retrospectively. Oncologic outcomes included 3-year overall survival (OS) and disease free survival, factors affecting them, and risk factors for local and systemic recurrence. Results: No difference was found between laparoscopic surgery and conventional open surgery in terms of OS, disease free survival rate at stages I and II, but the 3-year OS for stage III was different between the groups (70.26% for conventional open surgery vs. 90.14% for laparoscopic surgery; P=0.0002). The 3-year disease free survival rate for stage III was 56.59% for conventional open surgery vs. 56.65% for laparoscopic surgery (P=0.6578). The local recurrence rates were 6.81% vs. 8.47% (conventional open surgery vs. laparoscopic surgery; P=0.4960). The systemic recurrence rates were 15.64% vs. 15.71% (conventional open surgery vs. laparoscopic surgery; P=0.9713). Conclusion: Laparoscopic surgery for rectal cancer showed a similar short-term oncologic outcome to conventional open surgery. This suggests that laparoscopic surgery is an acceptable alternative to conventional open surgery for selected patients with rectal cancer.